Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Sleep in Critically Ill Patients
NCT04631510Phase 1Completed
- Sponsor
- Tufts Medical Center
- Start
- Dec 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of gabapentin in sleep disorder, sponsored by Tufts Medical Center. Primary endpoint: Change in Sleep Efficiency at 12 hours. Started Dec 2020; status: completed.
02
Drugs
gabapentin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT04631510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04631510.